Early Intervention in Cystic Fibrosis: CFTR-Related Organ Damage Progression from in Utero through Adulthood
A free evening CME/CNE/MOC seminar with food and drinks
This engaging multimedia program will feature expert faculty, animations, interactive polling with immediate feedback, and an infographic clinical reference aid to help attendees convert information into practice.
You do not have to attend the conference to register for this seminar.
Date & Location:
Denver, CO – Thursday, October 18, 2018
Hyatt Regency Denver
650 15th St., Denver, CO 80202
Meeting Room: Capitol Ballroom
The symposium is from 7:30 p.m. to 9:00 p.m.
Registration, complimentary hors d'oeuvres and drinks begin at 7:00 p.m.
Pulmonologists, pediatricians, infectious disease physicians, gastroenterologists, advanced practice providers, registered nurses, and allied health providers involved in the care of patients with cystic fibrosis.
Upon completion of this activity, the participant will be better able to:
Review the impact of CF across the lung and gastrointestinal (GI) organ systems starting in utero.
Discuss methods to detect asymptomatic disease progression in GI and lung organ systems in CF patients.
Describe intervention strategies to address early GI and lung manifestations of disease progression to optimize patient outcomes.
Review recent evidence, guidelines, and best practices in personalized treatment selection according to CFTR mutation classification.
Pamela L. Zeitlin, MD, MPhil, PhD (Program Chair)
Silverstein Chair, Department of Pediatrics
Professor of Pediatrics
National Jewish Health, Denver, CO
Milene Saavedra, MD
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health, Denver, CO
Raj J. Shah MD, FASGE, AGAF
Professor of Medicine
Director, Pancreaticobiliary Endoscopy
University of Colorado, Aurora, CO
For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email firstname.lastname@example.org.
You are registered for a meeting ONLY when a red box stating confirmation of registration appears on your screen when you click submit, and then an email confirmation is received in your inbox. If you have questions, please call 800.844.2305.
Accreditation and Designation Statements:
Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this live educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Registered Nurses: Provider approved by the California Board of Registered Nursing, Provider Number 12724, for 1.8 contact hours.
This activity is supported by an independent educational grant from Vertex Pharmaceuticals Incorporated.